Canada Goose Reports 73% Drop in Annual Net Income Despite Revenue Growth
summarizeSummary
Canada Goose Holdings Inc. announced a significant decline in fiscal year 2026 net income and EPS, driven by increased operating expenses and one-time charges, despite overall revenue growth.
check_boxKey Events
-
Significant Profitability Decline
Net income for fiscal year 2026 plummeted by 73.2% to $27.8 million, and basic earnings per share fell by 76.5% to $0.23, compared to the prior year.
-
Revenue Growth
Total revenue increased by 13.3% to $1,528.2 million for fiscal year 2026, driven by strong DTC comparable sales growth of 8.4% and wholesale segment growth.
-
Increased Operating Expenses
Selling, general, and administrative (SG&A) expenses surged by 25.4% to $976.7 million, significantly impacting operating income, which decreased by 45.9% to $88.8 million.
-
One-Time Arbitration Award and Store Impairments
SG&A expenses included a $43.8 million payment for an unfavorable arbitration award and $8.4 million in impairment losses on property, plant, and equipment due to underperforming retail stores.
auto_awesomeAnalysis
Canada Goose Holdings Inc. reported a substantial decline in fiscal year 2026 net income and earnings per share, despite a 13.3% increase in revenue. The significant drop in profitability is primarily attributed to a sharp rise in selling, general, and administrative (SG&A) expenses, which increased by 25.4%. This includes a one-time $43.8 million arbitration award payment and higher personnel costs. Additionally, the company recognized $8.4 million in impairment losses on property, plant, and equipment, mainly due to underperforming retail stores, indicating challenges in its Direct-to-Consumer (DTC) expansion strategy. While a share repurchase program was authorized, no shares were purchased under the Fiscal 2026 NCIB, limiting any potential positive impact from buybacks.
At the time of this filing, GOOS was trading at $9.82 on NYSE in the Manufacturing sector, with a market capitalization of approximately $960.6M. The 52-week trading range was $8.86 to $15.43. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.